Ave Mori
About Ave Mori
Ave Mori is the Associate European Medical Lead at Bristol-Myers Squibb, with extensive experience in oncology, immunology, and cardiovascular diseases, and a background in clinical trials and innovative medicine development.
Company
Ave Mori currently works at Bristol-Myers Squibb as the Associate European Medical Lead. With over 16 years of experience in this role, Ave Mori is deeply involved in the development of innovative medicines and clinical trials to bring new treatments to patients.
Previous Positions
Before assuming the role of Associate European Medical Lead at Bristol-Myers Squibb, Ave Mori served as an Oncology Project Leader at Bayer for three years. Earlier, Ave Mori was a Clinical Project Leader at Bristol-Myers Squibb for four years. Additionally, Ave Mori worked as a Clinical Program Leader at Pharmacia and Upjohn for one year and as a Consultant Oncologist at the same company for one year. Ave Mori also gained experience as a Voluntary Assistant at San Raffaele Hospital for one year and completed a five-year residency as a Resident Physician at the National Cancer Institute (NCI).
Education and Expertise
Ave Mori completed a fellowship in Medical Oncology at the National Cancer Institute (NCI). Before this, Ave Mori studied at the Università degli Studi di Genova. With a robust educational background and years of practical experience, Ave Mori specializes in immunology, oncology, and cardiovascular diseases.
Clinical Trials and Research
In the role of Associate European Medical Lead, Ave Mori actively engages in clinical trials and research to develop new medicines. Collaborating with academic institutions and research organizations globally, Ave Mori focuses on accelerating the discovery and development of new therapies. The utilization of advanced data analytics helps to optimize clinical trial designs, thereby improving the efficiency of drug development processes.
Improving Patient Access and Health Equity
Ave Mori supports patient access to medications through various programs and initiatives. Actively advocating for policies that promote health equity, Ave Mori seeks to improve access to care for underserved patients. Through involvement with the Bristol Myers Squibb Foundation, Ave Mori focuses on promoting health equity, especially for populations disproportionately affected by serious diseases.